# Effect of Smartphone App on Activity

Study · id `cardio:ct-nct02612402` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02612402](<https://clinicaltrials.gov/study/NCT02612402>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02612402

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 270 participants.

## Technical summary

Registry record NCT02612402. Randomized; triple masking; primary purpose supportive care. Start 2014-07 (registry gives no type); primary completion 2017-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 270 participants (planned count; ClinicalTrials.gov record NCT02612402, source copy `cardio:ctgov-nct02612402-2015-11-23`, retrieved 2026-10-26)
- Start date: 2014-07 (registry gives no type) (ClinicalTrials.gov record NCT02612402, source copy `cardio:ctgov-nct02612402-2015-11-23`, retrieved 2026-10-26)
- Primary completion: 2017-07 (anticipated) (ClinicalTrials.gov record NCT02612402, source copy `cardio:ctgov-nct02612402-2015-11-23`, retrieved 2026-10-26)
- Completion: 2017-07 (anticipated) (ClinicalTrials.gov record NCT02612402, source copy `cardio:ctgov-nct02612402-2015-11-23`, retrieved 2026-10-26)
- Countries: Israel (ClinicalTrials.gov record NCT02612402, source copy `cardio:ctgov-nct02612402-2015-11-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02612402-2015-11-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Smartphone App on Activity
- Condition: Diabetes Type 2
- Condition: Hematologic Malignancy
- Intervention (Device): messages generated by learning algorithm
- Intervention (Device): constant weekly message reminding patient to exercise
- Lead sponsor: Rambam Health Care Campus
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Rambam Health Care Campus (`cardio:org-rambam-health-care-campus`)

## Provenance

Content hash: 68610519dd539858f1ae0133258899ccb00a434e5e86ce6fb160f95a19c95a2b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
